• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因低氧性呼吸衰竭入院的新冠肺炎患者的治疗结果

Outcomes of Hospitalised COVID-19 Patients Arriving With Hypoxic Respiratory Failure.

作者信息

Giesing William, Soney Hywel, Wang Lucas, Hoang Lawrence, Cui Mingyang, Prathivada Sri, Sidhu Manavjot

机构信息

Department of Internal Medicine, Methodist Dallas Medical Center, Dallas, TX, USA.

Department of Internal Medicine, Methodist Dallas Medical Center, Dallas, TX, USA.

出版信息

Heart Lung Circ. 2024 Dec;33(12):1688-1692. doi: 10.1016/j.hlc.2023.10.023. Epub 2024 Jul 14.

DOI:10.1016/j.hlc.2023.10.023
PMID:39004555
Abstract

BACKGROUND

Hypoxia is a common complication seen in people with COVID-19 and can often be the presenting symptom.

METHODS

Using a multi-centre observational database, we analysed 3,624 hospitalised COVID-19 PCR-positive patients at Methodist Health System, Dallas, Texas, USA from March 2020 to December 2020. We compared in-hospital death or hospice referral rates and major adverse cardiovascular events (MACE) between patients with four levels of oxygen (O) requirements (0-1 L/min, 2-10 L/min, 11-20 L/min, 21-100 L/min). MACE included congestive heart failure (CHF) exacerbations, myocardial infarctions (MI), strokes, pulmonary embolism (PE) / deep venous thrombosis (DVT), and shock. Logistic regression analysis was used to determine comorbidities and demographics associated with mortality. Multinomial regression analysis was used to find which of these variables were associated with hypoxia.

RESULTS

Patients who arrived needing 0-1 L/min of O had reduced risk of mortality compared to those requiring 2-10 L/min (OR=1.54, 95% CI=1.207-1.976, p<0.0001), 11-20 L/min (OR=4.55, 95% CI=3.169-6.547, p<0.0001), or 21-100 L/min (OR=12.06, 95% CI=8.548-17.016, p<0.0001). In addition, patients who arrived needing 0-1 L/min of O showed reduced risk of MACE compared to those requiring 2-10 L/min (OR=1.20, 95% CI=1.029-1.409, p<0.0001), 11-20 L/min (OR=2.76, 95% CI 2.06-3.696, p<0.0001), or 21-100 L/min (OR=6.74, 95% CI 4.966-9.155, p<0.0001).

CONCLUSION

Hypoxia on arrival is associated with a significantly increased risk of mortality and MACE among hospitalised patients with COVID-19. This data will promote better prognostication and help reduce negative outcomes in an inpatient setting.

摘要

背景

缺氧是新型冠状病毒肺炎患者常见的并发症,且常常是首发症状。

方法

利用一个多中心观察数据库,我们分析了2020年3月至2020年12月在美国得克萨斯州达拉斯卫理公会医疗系统住院的3624例新型冠状病毒肺炎核酸检测呈阳性的患者。我们比较了四个吸氧(O)需求水平(0 - 1升/分钟、2 - 10升/分钟、11 - 20升/分钟、21 - 100升/分钟)患者的院内死亡或临终关怀转诊率以及主要不良心血管事件(MACE)。MACE包括充血性心力衰竭(CHF)加重、心肌梗死(MI)、中风、肺栓塞(PE)/深静脉血栓形成(DVT)和休克。采用逻辑回归分析来确定与死亡率相关的合并症和人口统计学特征。采用多项回归分析来找出这些变量中哪些与缺氧相关。

结果

与需要2 - 10升/分钟吸氧的患者相比,入院时需要0 - 1升/分钟吸氧的患者死亡风险降低(比值比[OR]=1.54,95%置信区间[CI]=1.207 - 1.976,p<0.0001),与需要11 - 20升/分钟吸氧的患者相比(OR=4.55,95% CI=3.169 - 6.547,p<0.0001),以及与需要21 - 100升/分钟吸氧的患者相比(OR=12.06,95% CI=8.548 - 17.016,p<0.0001)。此外,入院时需要0 - 1升/分钟吸氧的患者与需要2 - 10升/分钟吸氧的患者相比,发生MACE的风险降低(OR=1.20,95% CI=1.029 - 1.409,p<0.0001),与需要11 - 20升/分钟吸氧的患者相比(OR=2.76,95% CI 2.06 - 3.696,p<0.0001),以及与需要21 - 100升/分钟吸氧的患者相比(OR=6.74,95% CI 4.966 - 9.155,p<0.0001)。

结论

入院时缺氧与新型冠状病毒肺炎住院患者的死亡风险和MACE显著增加相关。这些数据将有助于更好地进行预后评估,并有助于减少住院患者的不良结局。

相似文献

1
Outcomes of Hospitalised COVID-19 Patients Arriving With Hypoxic Respiratory Failure.因低氧性呼吸衰竭入院的新冠肺炎患者的治疗结果
Heart Lung Circ. 2024 Dec;33(12):1688-1692. doi: 10.1016/j.hlc.2023.10.023. Epub 2024 Jul 14.
2
Prophylactic anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的预防性抗凝治疗。
Cochrane Database Syst Rev. 2020 Oct 2;10(10):CD013739. doi: 10.1002/14651858.CD013739.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.在一个多机构医疗系统中,2019冠状病毒病检测呈阳性的住院患者发生深静脉血栓形成和肺栓塞预示着更高的死亡率以及更长的重症监护病房住院时间和医院住院时间。
J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1361-1370.e1. doi: 10.1016/j.jvsv.2021.03.009. Epub 2021 Apr 6.
5
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.一项评估巴瑞替尼预防 COVID19 相关血液肿瘤患者呼吸功能不全进展的疗效的 I/II 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):116. doi: 10.1186/s13063-021-05072-4.
6
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
7
Association among diabetes, cardiovascular disease and mortality in patients hospitalised for COVID-19: an analysis of the American Heart Association COVID-19 CVD Registry.2019冠状病毒病住院患者中糖尿病、心血管疾病与死亡率之间的关联:美国心脏协会2019冠状病毒病心血管疾病注册研究分析
BMJ Open. 2024 Dec 4;14(12):e084087. doi: 10.1136/bmjopen-2024-084087.
8
Association of Sleep-Related Hypoxia With Risk of COVID-19 Hospitalizations and Mortality in a Large Integrated Health System.睡眠相关缺氧与大型综合医疗系统中 COVID-19 住院和死亡风险的关联。
JAMA Netw Open. 2021 Nov 1;4(11):e2134241. doi: 10.1001/jamanetworkopen.2021.34241.
9
Non-invasive positive pressure ventilation versus endotracheal intubation in treatment of COVID-19 patients requiring ventilatory support.经鼻高流量湿化氧疗与无创通气在新型冠状病毒肺炎患者中的应用比较
Am J Emerg Med. 2021 May;43:103-108. doi: 10.1016/j.ajem.2021.01.068. Epub 2021 Jan 29.
10
Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease.COVID-19 合并心血管疾病史患者的死亡率和主要不良事件的高风险。
Open Heart. 2021 Apr;8(1). doi: 10.1136/openhrt-2020-001526.

引用本文的文献

1
Epidemiology and SARIMA model of deaths in a tertiary comprehensive hospital in Hangzhou from 2015 to 2022.2015 年至 2022 年杭州市某三级综合医院死亡病例的流行病学及 SARIMA 模型分析。
BMC Public Health. 2024 Sep 19;24(1):2549. doi: 10.1186/s12889-024-20033-7.